TRex Bio raised $116.7 million in a U.S. IPO, pricing at the bottom of its range
- U.S. IPO 近 90 天出现 6 次
- 上一次：同一天稍早 · 7-Eleven's U.S. IPO timing will hinge on turnaround progress, CEO says
发生了什么
The clinical-stage biotech sold about 8.3 million shares at $14 each, the low end of its $14-to-$16 marketed range
摘要按规则整理自下方来源原文